Tradestie Institutional Equity Comparison Engine

BHST vs ELVA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ELVA Overall Edge

ELVA Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Electrovaya Inc. Common Shares (ELVA) driven by superior Valuation, Growth & Margin while BHST counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, BHST trades at N/M Forward P/E with -18.0% operating margin (+3.8% YoY revenue) versus ELVA at 18.4x Forward P/E and 9.3% operating margin (+3.4% YoY). In options structure, BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ELVA sits in BREAKDOWN (28th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ELVA
BHST N/M vs ELVA 18.4x Fwd P/E
Growth & Margin Winner ELVA
Op Margin -18.0% vs 9.3% ยท YoY +3.8% vs +3.4%
Momentum & Technical Winner BHST
1Y -79.4% vs -27.8% ยท 52W Pos 6% vs 0%
Options & Structure Winner BHST
UNCLASSIFIED (N/A IV) vs BREAKDOWN (28th %ile IV)
BHST NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
1M Return -22.62%
1Y Return -79.4%
Forward P/E N/M
Unified AI Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0
ELVA NASDAQ
Electrovaya Inc. Common Shares
Miscellaneous Electrical Machinery, Equipment & Supplies
$3.27
-11.86% 1D
Market Cap $185.5M
1M Return -37.12%
1Y Return -27.81%
Forward P/E 18.4x
Unified AI Score
41.0 / 100 SELL
Tech 25.0 Fund 48.0 Flow 66.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BHST -79.4% ELVA -27.81% Spread: +51.59 pp (ELVA Lead)

Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period BHST Revenue ELVA Revenue BHST Op. Margin ELVA Op. Margin Margin Edge
Q2 '25 $30M $70M -21.3% 11.5% ELVA
Q3 '25 $40M $80M -10.1% 11.7% ELVA
Q4 '25 $40M $60M -12.4% 8.8% ELVA
Q1 '26 $30M $70M -21.6% 12.1% ELVA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BHST (4) vs ELVA (6)
Institutional Metric BHST ELVA Criterion Row Winner
Market Capitalization Scale $29.9M $185.5M Larger Scale ELVA
Trailing P/E Ratio Valuation N/M 37.1x Lower Multiple ELVA
Forward P/E Ratio Valuation N/M 18.4x Lower Multiple ELVA
Revenue Growth (YoY) Growth +3.8% +3.4% Higher Growth BHST
Operating Margin (TTM) Profitability -18.0% 9.3% Higher Margin ELVA
Net Profit Margin Profitability -31.2% 6.1% Higher Margin ELVA
Return on Equity (ROE) Capital Efficiency -142.5% 9.8% Higher ROE ELVA
52-Week Range Position Momentum 6% ($1โ€“$7) 0% ($3โ€“$13) Stronger Trend BHST
Beta / 30D Volatility Risk Regime 0.25ฮฒ ยท 86% Vol 3.51ฮฒ ยท 89% Vol Lower Realized Risk BHST
Unified Institutional Score Composite Signal 58.2 / 100 (HOLD) 41.0 / 100 (SELL) Higher Composite BHST

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BHST vs ELVA Buy Guide
BHST UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BHST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ELVA BREAKDOWN
120d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 28th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ELVA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BHST nor ELVA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.